Ann: Progress on Assay Development Program, page-46

"BARD1 signs Assay Development Agreement with Thermo Fisher Scientific for Multiplex Research-Use-Only (RUO) Custom Assay Development" It is clear what TH was to do and " with deliverables including Assay Feasibility Report, Development Report, Protocol, Standard Operating Procedures, Assay Validation Report, BARD1-autoantibody kits for research and evaluation, and transfer documentation."

The very brief announcement by BD1 that the transfer had occurred in June 19 on schedule has almost certainly included all of the items from the 18/5/2018

Almost put this in the Bright Side. The jump to day to 0.028 before settling at 0.26 above the 0.025 open suggested a possiblty a few others are happily soaking up any cheap shares. I still think about 0.03 is where we might hold until the test kits are validated and the negotiations with Luminex to develop a commercial diagnostic version has us singing 'we're in the money'. Not up ramping. My new $00.02CR and all my shares remain in my holding.